SCHEMBL513885

SCHEMBL513885

CCO/C(C)=N/O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL513886 1.00
SCHEMBL4154727 1.00
SCHEMBL8022541 0.77
SCHEMBL11621776 0.75
SCHEMBL8546157 0.75
SCHEMBL11996350 0.75
SCHEMBL23913817 0.73
SCHEMBL6036832 0.73
SCHEMBL10081779 0.73
SCHEMBL10063335 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709725-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2026-03-18 EP disclosed
US-20260042731-A1 (2,4-DICHLOROPHENOXY)ACETIC ACID ANALOGS CORTEVA AGRISCIENCE LLC (US) 2026-02-12 US disclosed
EP-4644396-A1 TOLL-LIKE RECEPTOR INHIBITOR, AND PREPARATION THEREFOR AND APPLICATION THEREOF Visionpharma (Nantong) Co., Ltd (CN) 2025-11-05 EP disclosed
WO-2025121401-A1 PYRAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT 日産化学株式会社 2025-06-12 WO disclosed
US-20250129067-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF PROGENTOS THERAPEUTICS, INC. (US) 2025-04-24 US disclosed
US-20240391931-A1 TRICYCLIC FUSED PYRIMIDINE COMPOUNDS FOR USE AS HER2 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2024-11-28 US disclosed
WO-2024233642-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PROGENTOS THERAPEUTICS, INC. (US) 2024-11-14 WO disclosed
EP-4430047-A1 PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR) ALPHA INHIBITORS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2024-09-18 EP disclosed
WO-2024182778-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2024-09-06 WO disclosed
CN-118475580-A Platelet-derived growth factor receptor (PDGFR) alpha inhibitors and uses thereof 普罗根托斯治疗公司 2024-08-09 CN disclosed
WO-1996040662-A2 AMINOOXY-CONTAINING LINKER COMPOUNDS AND THEIR APPLICATION IN CONJUGATES CELLPRO, INCORPORATED (US) 1996-12-19 WO disclosed
WO-1995032184-A1 SYSTEMATIC MODULAR PRODUCTION OF AMINIMIDE- AND OXAZOLONE- BASED MOLECULES HAVING AT LEAST TWO STRUCTURAL DIVERSITY ELEMENTS ARQULE, INC. (US) 1995-11-30 WO disclosed
EP-0334863-B1 PROCESS FOR THE PREPARATION OF ORGANO N-HYDROXYIMIDATES AlliedSignal Inc. (US) 1992-04-15 EP disclosed
EP-0334863-A1 PROCESS FOR THE PREPARATION OF ORGANO N-HYDROXYIMIDATES. ALLIED CORP (US) 1989-10-04 EP disclosed
WO-1988004291-A1 PROCESS FOR THE PREPARATION OF ORGANO N-HYDROXYIMIDATES ALLIED CORPORATION (US) 1988-06-16 WO disclosed
US-4743701-A Process for the preparation of organo N-hydroxyimidates ALLIED CORPORATION (US) 1988-05-10 US disclosed
US-4675340-A Insecticidal and miticidal oxime N-alkyl-N-α-haloacylcarbamate derivatives, compositions, and method of use therefor UNION CARBIDE CORPORATION (US) 1987-06-23 US disclosed
US-4614813-A Process for the preparation of N-hydroxy organo imidate compounds ALLIED CORPORATION (US) 1986-09-30 US disclosed
US-4576965-A MITICIDES, INSECTICIDES UNION CARBIDE CORPORATION (US) 1986-03-18 US disclosed
EP-0158153-A2 Process for the preparation of N-hydroxy organo imidate compounds ALLIED CORPORATION (US) 1985-10-16 EP disclosed